Carole Dufouil1,2, Alexa Beiser3, Geneviève Chêne1,2, Sudha Seshadri3,4. 1. Inserm, Bordeaux Population Health Research Center, UMR, Univ. Bordeaux, ISPED, Bordeaux School of Public Health, France. 2. CHU de Bordeaux, Pôle de santé publique, France. 3. Boston University Schools of Public Health and Medicine and the Framingham Heart Study, Massachusetts. 4. Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Sciences Center, San Antonio.
Abstract
Objectives: Several epidemiological studies suggest declining trends in dementia over the last three decades with both decreasing age-specific prevalence and incidence. There is limited data on whether this delayed clinical onset is accompanied by a shorter postdiagnosis survival. Methods: A total of 5,205 participants from the Framingham Original and Offspring cohorts were studied. Four epochs were considered from 1977-1984 to 2004-2008. Gender and education adjusted 5-year mortality risks were estimated using delayed entry Cox models with the earliest epoch as reference category. Stratified analyses by sex, education, and age were undertaken. A nested case control study of 317 dementia cases and 317 controls matched on age, gender and epoch was initiated. Results: In the whole sample, 5-year mortality risk has decreased with time, it was 33% lower in the last epoch compared to the earliest. In the 317 persons who developed dementia, age at onset increased (1.5 years/epoch), and years alive with dementia decreased (1 year/epoch) over time. We observed however, a decreased adjusted relative mortality risk (by 18%) in persons with dementia in 1986-1991 compared to 1977-1983 and no significant change from then to the latest epoch. The nested case control study suggested in matched controls that 5-year mortality relative risk had increased by 60% in the last epoch compared to Epoch 1. Discussion: In the FHS, in the last 30 years, disease duration in persons with dementia has decreased. However, age-adjusted mortality risk has slightly decreased after 1977-1983. Consequences of such trends on dementia prevalence should be investigated.
Objectives: Several epidemiological studies suggest declining trends in dementia over the last three decades with both decreasing age-specific prevalence and incidence. There is limited data on whether this delayed clinical onset is accompanied by a shorter postdiagnosis survival. Methods: A total of 5,205 participants from the Framingham Original and Offspring cohorts were studied. Four epochs were considered from 1977-1984 to 2004-2008. Gender and education adjusted 5-year mortality risks were estimated using delayed entry Cox models with the earliest epoch as reference category. Stratified analyses by sex, education, and age were undertaken. A nested case control study of 317 dementia cases and 317 controls matched on age, gender and epoch was initiated. Results: In the whole sample, 5-year mortality risk has decreased with time, it was 33% lower in the last epoch compared to the earliest. In the 317 persons who developed dementia, age at onset increased (1.5 years/epoch), and years alive with dementia decreased (1 year/epoch) over time. We observed however, a decreased adjusted relative mortality risk (by 18%) in persons with dementia in 1986-1991 compared to 1977-1983 and no significant change from then to the latest epoch. The nested case control study suggested in matched controls that 5-year mortality relative risk had increased by 60% in the last epoch compared to Epoch 1. Discussion: In the FHS, in the last 30 years, disease duration in persons with dementia has decreased. However, age-adjusted mortality risk has slightly decreased after 1977-1983. Consequences of such trends on dementia prevalence should be investigated.
Authors: Kenneth M Langa; Eric B Larson; Jason H Karlawish; David M Cutler; Mohammed U Kabeto; Scott Y Kim; Allison B Rosen Journal: Alzheimers Dement Date: 2008-03-04 Impact factor: 21.566
Authors: Ramachandran S Vasan; Lisa M Sullivan; Peter W F Wilson; Christopher T Sempos; Johan Sundström; William B Kannel; Daniel Levy; Ralph B D'Agostino Journal: Ann Intern Med Date: 2005-03-15 Impact factor: 25.391
Authors: E M C Schrijvers; B F J Verhaaren; P J Koudstaal; A Hofman; M A Ikram; M M B Breteler Journal: Neurology Date: 2012-05-02 Impact factor: 9.910
Authors: Maria Guzman-Castillo; Sara Ahmadi-Abhari; Piotr Bandosz; Simon Capewell; Andrew Steptoe; Archana Singh-Manoux; Mika Kivimaki; Martin J Shipley; Eric J Brunner; Martin O'Flaherty Journal: Lancet Public Health Date: 2017-05-23
Authors: Fiona E Matthews; Antony Arthur; Linda E Barnes; John Bond; Carol Jagger; Louise Robinson; Carol Brayne Journal: Lancet Date: 2013-07-17 Impact factor: 79.321